Printer Friendly Version
Printer Friendly Version
S.5.01.602
Ycanth (cantharidin)
Please perform a search of the State Health Plan Medical Drug Formulary for drugs administered and billed through the medical setting.
Ycanth (cantharidin) is indicated for the topical treatment of molluscum contagiosum in adult and pediatric patients 2 years of age and older.
Ycanth (cantharidin) is considered not medically necessary as other options covered by the Plan for the treatment of molluscum contagiosum.
Services related to delivery and/or administration of a medication determined to be not medically necessary will also be considered not medically necessary.
None
Medical Policy Manual coverage guidelines should not be used in lieu of the Participant's specific benefit plan language outlined in the Mississippi's State and School Employees’ Life and Health Insurance Plan.
Medically Necessary is defined as those services, treatments, procedures, equipment, drugs, devices, items or supplies furnished by a covered Provider that are required to identify or treat a Participant's illness, injury or Mental Health Disorders, and which Company determines are covered under this Benefit Plan based on the criteria as follows in A through D:
consistent with the symptoms or diagnosis and treatment of the Participant's condition, illness, or injury; and
appropriate with regard to standards of good medical practice; and
not solely for the convenience of the Participant, his or her Provider; and
the most appropriate supply or level of care which can safely be provided to Participant. When applied to the care of an Inpatient, it further means that services for the Participant's medical symptoms or conditions require that the services cannot be safely provided to the Participant as an Outpatient.
For the definition of medical necessity, “standards of good medical practice” means standards that are based on credible scientific evidence published in peer-reviewed medical literature generally recognized by the relevant medical community, and physician specialty society recommendations, and the views of medical practitioners practicing in relevant clinical areas and any other relevant factors. BCBSMS makes no payment for services, treatments, procedures, equipment, drugs, devices, items or supplies which are not documented to be Medically Necessary. The fact that a Physician or other Provider has prescribed, ordered, recommended, or approved a service or supply does not in itself, make it Medically Necessary.
05/01/2024: New policy added.
03/20/2025: Policy reviewed and approved by the Pharmacy & Therapeutics (P&T) Committee. Policy statements unchanged. Sources updated.
Ycanth prescribing information. Verrica Pharmaceuticals Inc. November 2024. Last accessed February 2025.
This may not be a comprehensive list of procedure codes applicable to this policy.
Not Medically Necessary Codes
Code Number | Description |
CPT-4 | |
HCPCS | |
J7354 | Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg) |
ICD-10 Procedure | |
ICD-10 Diagnosis |
CPT copyright American Medical Association. All rights reserved. CPT is a registered trademark of the American Medical Association.